These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1761810)

  • 21. Oral treatment for constitutional delay of growth and puberty in boys: a randomised trial of an anabolic steroid or testosterone undecanoate.
    Albanese A; Kewley GD; Long A; Pearl KN; Robins DG; Stanhope R
    Arch Dis Child; 1994 Oct; 71(4):315-7. PubMed ID: 7979523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-year results of treatment with growth hormone, alone or associated with oxandrolone, in girls with Turner syndrome. The Kabi Collaborative Study Group.
    Job JC; Landier F
    Horm Res; 1991; 35(6):229-33. PubMed ID: 1819547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of constitutional delay of growth and puberty with oxandrolone compared with growth hormone.
    Buyukgebiz A; Hindmarsh PC; Brook CG
    Arch Dis Child; 1990 Apr; 65(4):448-9. PubMed ID: 2346341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone.
    Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H
    J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Growth hormone treatment in short stature of unknown origin].
    Wit JM
    Tijdschr Kindergeneeskd; 1992 Oct; 60(5):164-72. PubMed ID: 1448806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of patients with Ullrich-Turner syndrome with conventional doses of growth hormone and the combination with testosterone or oxandrolone: effect on growth, IGF-I and IGFBP-3 concentrations.
    Haeusler G; Frisch H; Schmitt K; Blümel P; Plöchl E; Zachmann M; Waldhör T
    Eur J Pediatr; 1995 Jun; 154(6):437-44. PubMed ID: 7545577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
    Lanes R; Jakubowicz S
    J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combined effect of growth hormone and oxandrolone in patients with growth hormone deficiency.
    Romshe CA; Sotos JF
    J Pediatr; 1980 Jan; 96(1):127-31. PubMed ID: 7350292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of growth delay in boys with isolated growth hormone deficiency.
    Albanese A; Stanhope R
    Eur J Endocrinol; 1994 Jan; 130(1):65-9. PubMed ID: 8124480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of growth hormone monotherapy and growth hormone in combination with oxandrolone or testosterone on thyroxid hormone parameters and thyroxine binding globulin in patients with Ullrich-Turner syndrome.
    Schmitt K; Häusler G; Blümel P; Plöchl E; Waldhör T; Frisch H
    Eur J Pediatr; 1997 Feb; 156(2):99-103. PubMed ID: 9039510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose growth hormone treatment of short children born small for gestational age.
    de Zegher F; Maes M; Gargosky SE; Heinrichs C; Du Caju MV; Thiry G; De Schepper J; Craen M; Breysem L; Löfström A; Jönsson P; Bourguignon JP; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1996 May; 81(5):1887-92. PubMed ID: 8626853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Final height in a patient with Laron syndrome after long-term therapy with rhlGF-I and short-term therapy with LHRH-analogue and oxandrolone during puberty.
    Zucchini S; Scarano E; Baldazzi L; Mazzanti L; Pirazzoli P; Cacciari E
    J Endocrinol Invest; 2005 Mar; 28(3):274-9. PubMed ID: 15952414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A longitudinal study of craniofacial growth in idiopathic short stature and growth hormone-deficient boys treated with growth hormone.
    Kjellberg H; Wikland KA
    Eur J Orthod; 2007 Jun; 29(3):243-50. PubMed ID: 17513878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anabolic steroid oxandrolone increases muscle mass in prepubertal boys with constitutional delay of growth.
    Papadimitriou A; Preece MA; Rolland-Cachera MF; Stanhope R
    J Pediatr Endocrinol Metab; 2001 Jun; 14(6):725-7. PubMed ID: 11453521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive factors in the determination of final height in boys with constitutional delay of growth and puberty.
    Albanese A; Stanhope R
    J Pediatr; 1995 Apr; 126(4):545-50. PubMed ID: 7699531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
    Rosenfeld RG
    Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation of growth hormone secretion in children with constitutional growth delay by short term clonidine administration: a pulse amplitude-modulated phenomenon.
    Loche S; Puggioni R; Fanni T; Cella SG; Müller EE; Pintor C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):426-30. PubMed ID: 2918053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome.
    Rosenfeld RG; Frane J; Attie KM; Brasel JA; Burstein S; Cara JF; Chernausek S; Gotlin RW; Kuntze J; Lippe BM
    J Pediatr; 1992 Jul; 121(1):49-55. PubMed ID: 1625092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.